Free access

The author and journal apologise for an error that occurred in the paper by Seccia et al. in the March 2005 issue of Endocrine-Related Cancer 12 149–159, entitled ‘Aldosterone-producing adrenocortical carcinoma: an unusual cause of Conn’s syndrome with an ominous clinical course’. The error relates to the measurement unit for increase of aldosterone from the upper normal value, which should be fold increase and not % as erroneously printed in Table 1 on page 153. The corrected table is published in full below:

Table 1

Demographic and clinical features. Median and range are given for age, diameter and weight; average and range are given for fold increase of plasma aldosterone levels; means ± S.E. are given for systolic and diastolic blood pressure, and plasma potassium levels

Variables Value
M, male; F, female; NA, not available; R, right; L, left.
Age (years) 44 (17–79)
Gender (M/F/NA) (n) 21/27/10
Side of tumour (R/L/NA) (n) 26/18/14
Maximum tumour diameter (mm) 70 (25–150)
Tumour mass weight (g) 248 (6.3–1250)
Systolic Blood Pressure (mmHg) 188 ± 4
Diastolic Blood Pressure (mmHg) 111 ± 2
Hypertension (n of cases; %) 55 (95%)
Plasma potassium levels (mmEq/L) 2.30 ± 0.08
Hypokalaemia (present/absent/NA) (n, %) 56 (96%)/1 (1.7%)/1 (1.7%)
Low Plasma Renin Activity (present/absent/NA) (n, %) 32 (55%)/10 (17%)/16 (27%)
Increase of aldosterone from the upper normal value (fold increase) 14 (1.1–333)
Adrenalectomy (performed/not performed/NA) 52/4/2


  • Collapse
  • Expand